Loading...

PREVEST Prevest Denpro Ltd Product Launches Announcement

Prvs

PRVS

Prevest Denpro Ltd

(PREVEST)

2023 Announcement

Show Summary

Show Summary

Strategic MoU Signed

Earnings Call Transcript

Investor Call Recording

Compliance Exemption

Investor Presentation

Investor Meeting

Operations Update

Board Meeting Rescheduled

Compliance Certificate

Investor Presentation

Investment in Axiodent

Funds Utilization Update

Compliance Certificate

Earnings Call Transcript

Earnings Call Recording

Investor Presentation

Investor Meeting

IPO Fund Utilization

Regulatory Compliance

Cost Auditor Appointment

Investor Presentation

AGM Announcement

Funds Utilization Statement

Financial Results & Dividend

Compliance Certificate

Price Movement Clarification

Earnings Call Transcript

Investor Call Outcome

Investor Presentation

Utilization of IPO Funds

Compliance Exemption

Rescheduled Board Meeting

Certificate Submission

Compliance Certificate Issued

Certificate Submission

R&D Recognition

Earnings Call Transcript

Investor Call Outcome

Presentation Submission

Additional Details Required

Utilization of IPO Funds

Certificate Received

Conference Call Transcript

Investor Call Recording Sub...

IPO Funds Utilization

Meeting Schedule

Investor Presentation

Analyst/Investor Meeting

Certificate Under Reg. 74(5...

Resignation of Company Secr...

Appointment of Company Secr...

Resignation of Company Secr...

Resignation of Company Secr...

Export Excellence Award

Financial Statements

Dividend Announcement

Investor Meetings

Financial Statements, Divid...

New Product Launches

Listing compliance

Asset Acquisitions

Rights Offerings

Investor Meetings

External Links:

Data:

Prevest Denpro Limited launched its new oral care product line, Oradox, at the World Dental Show, showcasing their commitment to delivering innovative dental care solutions.

AI Assistant

Prevest Denpro Ltd

2023

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.